143 related articles for article (PubMed ID: 20451671)
1. Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide.
Thanassoulas A; Nomikos M; Theodoridou M; Yannoukakos D; Mastellos D; Nounesis G
Biochim Biophys Acta; 2010 Sep; 1804(9):1908-16. PubMed ID: 20451671
[TBL] [Abstract][Full Text] [Related]
2. The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50.
Edwards RA; Lee MS; Tsutakawa SE; Williams RS; Nazeer I; Kleiman FE; Tainer JA; Glover JN
Biochemistry; 2008 Nov; 47(44):11446-56. PubMed ID: 18842000
[TBL] [Abstract][Full Text] [Related]
3. Thermal and chemical denaturation of the BRCT functional module of human 53BP1.
Thanassoulas A; Nomikos M; Theodoridou M; Stavros P; Mastellos D; Nounesis G
Int J Biol Macromol; 2011 Oct; 49(3):297-304. PubMed ID: 21600917
[TBL] [Abstract][Full Text] [Related]
4. Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants.
Choudhary RK; Vikrant ; Siddiqui QM; Thapa PS; Raikundalia S; Gadewal N; Kumar NS; Hosur MV; Varma AK
J Biomol Struct Dyn; 2016 Jul; 34(7):1533-44. PubMed ID: 26307947
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the BARD1 BRCT domains.
Birrane G; Varma AK; Soni A; Ladias JA
Biochemistry; 2007 Jul; 46(26):7706-12. PubMed ID: 17550235
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
Laufer M; Nandula SV; Modi AP; Wang S; Jasin M; Murty VV; Ludwig T; Baer R
J Biol Chem; 2007 Nov; 282(47):34325-33. PubMed ID: 17848578
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
Dizin E; Irminger-Finger I
Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
[TBL] [Abstract][Full Text] [Related]
8. Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50.
Choudhary RK; Siddiqui MQ; Thapa PS; Gadewal N; Nachimuthu SK; Varma AK
Sci Rep; 2017 Jun; 7(1):3849. PubMed ID: 28634376
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
Liu X; Ladias JA
Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
[TBL] [Abstract][Full Text] [Related]
10. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
Rodriguez M; Yu X; Chen J; Songyang Z
J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
[TBL] [Abstract][Full Text] [Related]
11. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
14. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
[TBL] [Abstract][Full Text] [Related]
15. Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage.
Wu W; Nishikawa H; Fukuda T; Vittal V; Asano M; Miyoshi Y; Klevit RE; Ohta T
Cancer Res; 2015 Apr; 75(7):1311-21. PubMed ID: 25634209
[TBL] [Abstract][Full Text] [Related]
16. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
17. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
[TBL] [Abstract][Full Text] [Related]
18. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
[TBL] [Abstract][Full Text] [Related]
19. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
[TBL] [Abstract][Full Text] [Related]
20. BARD1 is an ATPase activating protein for OLA1.
Chen T; Yeh HW; Chen PP; Huang WT; Wu CY; Liao TC; Lin SL; Chen YY; Lin KT; Hsu SD; Cheng HC
Biochim Biophys Acta Gen Subj; 2022 May; 1866(5):130099. PubMed ID: 35134491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
